Increase Surveillance for Breast and Ovarian Cancers, Also to Determine Targeted Risk-reducing and Preventative Strategies
Medical Provider Experience Assessment Healthcare Decisions Post-Testing, Risk Reducing, and Preventative Strategies Using BRCA2 and BRCA2 Genetic Testing
1 other identifier
observational
2,000
1 country
1
Brief Summary
Observational study is to increase surveillance for breast and ovarian cancers, also to determine targeted risk-reducing and preventative strategies.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2017
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 17, 2017
CompletedStudy Start
First participant enrolled
October 17, 2017
CompletedFirst Posted
Study publicly available on registry
October 24, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
October 17, 2020
CompletedJanuary 23, 2019
January 1, 2019
3 years
October 17, 2017
January 22, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Provider Structures and Processes
Plan of Care Changes due to BRCA testing. Provider based observational survey system on the health and well-being of patients and populations
36 months
Interventions
Genetic breast and ovarian cancer testing
Eligibility Criteria
Current standard operating procedures for providers
You may qualify if:
- Must be a Medical Practitioner
- Medical Doctor (MD)
- Doctor of Osteopathic (DO)
- Physician Assistant (PA)
- Advanced Practice Registered Nurse (APRN)
- Nurse Practitioner (NP)
- Must have a current standard operating procedure that includes obtaining/reviewing medical history and family medical history
You may not qualify if:
- Government-funded insurance data cannot be included in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
DCABM
Land O' Lakes, Florida, 33558, United States
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 17, 2017
First Posted
October 24, 2017
Study Start
October 17, 2017
Primary Completion
October 1, 2020
Study Completion
October 17, 2020
Last Updated
January 23, 2019
Record last verified: 2019-01
Data Sharing
- IPD Sharing
- Will not share